Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03515200
Title Treatment With Combination Chemotherapy for Relapsed or Refractory Acute Lymphoblastic Leukemia
Recruitment Terminated
Phase Phase I
Variant Requirements No
Sponsors St. Jude Children's Research Hospital

acute lymphoblastic leukemia


Cytarabine + Dexamethasone + Methotrexate

Bortezomib + Dasatinib + Dexamethasone + Doxorubicin + Palbociclib

Age Groups: adult | child
Covered Countries USA

No variant requirements are available.